REG - Maven Inc &Grwth VCT - Result of AGM

Maven Income and Growth VCTAnnouncement

11/07/2024 13:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240711:nRSK0962Wa&default-theme=true

RNS Number : 0962W  Maven Income & Growth VCT PLC  11 July 2024

 

Maven Income and Growth VCT PLC

 

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 6(th) Floor, Saddlers
House, 44 Gutter lane, London EC2V 6BR at 12.00 noon on Thursday 11 July 2024,
all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 9 July 2024, the
total number of voting rights in the Company stood at 161,238,518 and the
total shares in issue were 161,238,518. The Company advises that, for the
Annual General Meeting, valid proxy appointments were made in respect of
6,788,235 shares and that the number of proxy votes lodged for each Resolution
were as follows:

 

     Resolutions                                                        For        Discretion  Against    Withheld  Total
 1   To receive the Directors' Report and audited Financial Statements  5,368,999  1,365,902   47,660     5,674     6,788,235
 2   To approve the Directors' Remuneration Report                      4,712,225  1,377,221   455,194    243,595   6,788,235
 3   To approve the payment of a final dividend                         5,392,343  1,334,946   43,953     16,993    6,788,235

 4   To re-elect John Pocock as a Director                              4,706,786  1,368,902   247,676    464,871   6,788,235

 5   To re-elect Alison Fielding as a Director                          4,906,509  1,368,902   65,301     447,523   6,788,235

 6   To re-elect Andrew Harrington as a Director                        4,906,509  1,368,902   65,301     447,523   6,788,235

 7   To re-appoint Johnston Carmichael LLP as Auditor                   4,691,309  1,368,902   264,706    463,318   6,788,235
 8   To authorise the Directors to fix the remuneration of the Auditor  4,924,095  1,365,902   488,857    9,381     6,788,235
 9   To renew the Company's authority to allot shares                   4,585,182  1,334,946   773,118    94,989    6,788,235
 10  To authorise the Directors to disapply pre-emption rights          4,385,104  1,368,902   1,001,582  32,647    6,788,235
 11  To renew the Company's authority to purchase its own shares        5,132,728  1,334,946   279,299    41,262    6,788,235
 12  To amend the minimum notice period for a general meeting           4,668,943  1,365,902   732,062    21,328    6,788,235

 

A vote withheld is not a vote in law and any such votes have not been included
in the votes for or against the respective Resolutions. The voting figures
will be available to view at: mavencp.com/migvct
(http://www.mavencp.com/migvct) .

 

Passing of Resolutions under Special Business

Copies of Resolutions passed under Special Business have been submitted to the
National Storage Mechanism and will shortly be available for inspection at:
fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism
(https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism)

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

11 July 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSFMFEFELSEDW